Empirical validation of the English version of the Fear of Cancer Recurrence Inventory
Empirical validation of the English version of the Fear of Cancer Recurrence Inventory
复制标题
DOI：
10.1007/s11136-015-1088-2
复制
发表时间：
2016-02-01
影响因子：
3.5
通讯作者：
Devins, Gerald M.
中科院分区：
文献类型：
--
作者：
Lebel, Sophie;Simard, Sebastien;Devins, Gerald M.
目的癌症患者报告称，帮助管理对癌症复发（FCR）的恐惧是他们最大的未满足需求之一。FCR的研究受到该结构的验证、多维测量方法很少的限制。一个例外是癌症复发恐惧量表（FCRI），最初用法语开发并经过经验验证。本研究验证了英文版的FCRI。方法FCRI被翻译成英语使用的前向-后向翻译程序和试点测试与17名英语为母语的癌症患者。通过对42名双语癌症患者进行两种形式的管理，建立了法语和英语版本的跨文化等效性。最后，350名讲英语的乳腺癌、结肠癌、前列腺癌或肺癌患者被要求完成FCRI。一个月后，将135名被试再次邮寄给研究中心，以评价其重测信度。双语被试在两个版本上的回答没有项目偏差。验证性因素分析支持假设的七因素结构。英文版具有较高的内部一致性（总量表α = .96，各分量表α =.71-.94）和重测信度（总量表r = .88，各分量表r = 56-.87）。结论英文版FCRI是一种适用于乳腺癌、结肠癌、前列腺癌和肺癌患者的可靠有效的FCR测量工具。其多维性使其成为一种有吸引力的研究和临床工具，可以进一步加深我们对FCR的了解。
Purpose Cancer patients report that help in managing fear of cancer recurrence (FCR) is one of their greatest unmet needs. Research on FCR has been limited by the very few validated, multi-dimensional measures of this construct. One exception is the Fear of Cancer Recurrence Inventory (FCRI), originally developed and empirically validated in French. The present study validated the English version of the FCRI.Methods The FCRI was translated into English using a forward-backward translation procedure and pilot-tested with 17 English-speaking cancer patients. Cross-cultural equivalency of the French and English versions was established by administering both forms to 42 bilingual cancer patients. Last, 350 English-speaking breast, colon, prostate, or lung cancer patients were asked to complete the FCRI. A subsample (n = 135) was mailed the FCRI again one month later to evaluate test-retest reliability.Results The English translation of the FCRI was well accepted by participants. There was no item-bias when comparing bilingual participants' answers on both versions. A confirmatory factor analysis supported the hypothesized seven-factor structure. The English version has high internal consistency (alpha = .96 for the total scale and.71-.94 for the subscales) and test-retest reliability (r = .88 for the total scale and 56-.87 for the subscales).Conclusions The English version of the FCRI is a reliable and valid measure of FCR applicable to breast, colon, prostate, and lung cancer patients. Its multi-dimensional nature makes it an attractive research and clinical tool to further our knowledge of FCR.